Literature DB >> 10534237

Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?

C T Bever, G A Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10534237     DOI： 10.1212/wnl.53.7.1380

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

1.  Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.

Authors:  S Marckmann; E Wiesemann; R Hilse; C Trebst; M Stangel; A Windhagen
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

Review 2.  Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.

Authors:  Marjana Brkic; Sriram Balusu; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.